Hodgkin lymphoma (HL)

April 23, 2019

Epstein-Barr Vaccination Could Cut Risk of B-cell Lymphoma, Study Suggests

News

Chronic B-cell activation — which can happen because of infectious mononucleosis, commonly caused by the Epstein-Barr virus (EBV) — triggers an excessive proliferation of certain B cells, which can evolve into a B-cell lymphoma. Although ... Read more

June 14, 2017June 14, 2017

3D Signatures Advances Telo-HL Test to Determine Relapse Risk in Hodgkin’s Lymphoma Patients

News

A clinical trial validating Telo-HL‘s usefulness in determining the risk of relapse in Hodgkin’s lymphoma (HL) is underway, Canada’s 3D Signatures announced. This is Stage 3 of Telo-HL’s validation program. Both Stage 1, the ... Read more

March 20, 2017March 20, 2017

Hodgkin Lymphoma Survivors with Family History of Cancer at High Risk of Second Cancer, Study Says

News

People successfully treated for Hodgkin’s lymphoma (HL) are more likely to develop a second cancer if they have a close relative with that type of cancer. The most common second ... Read more